Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies

Immunotherapy
Till SeilerMartin Dreyling

Abstract

Advanced-stage follicular lymphoma has previously been described as an incurable disease. However, the introduction of monoclonal antibodies such as rituximab has considerably changed the management of the disease in the last decade with a significant subset of patients remaining in remission for a decade or longer. Rituximab, a CD20-targeting antibody, is approved for treatment both upfront and in the relapse setting. The most dramatic impact of this antibody is observed in combinations with conventional chemotherapy regimens. Encouraging results have also been reported from radiolabeled anti-CD20 antibodies. High response rates and durable remissions have been seen with both (90)Y-ibritumomab tiuxetan and (131)I-tositumomab. However, refractoriness to immunochemotherapy still remains a problem, especially in relapsed disease. Several novel targeted agents show encouraging activity in follicular lymphoma. This review will focus on current treatment strategies in this disease.

References

Dec 6, 1984·The New England Journal of Medicine·S J Horning, S A Rosenberg
Jan 1, 1997·Kidney & Blood Pressure Research·M E Safar, G M London
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Aug 12, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L D PiroV Jain
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Apr 12, 2003·Leukemia & Lymphoma·David G SavageGwen Nichols
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John P LeonardDavid M Goldenberg
Sep 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Kai Weng, Ronald Levy
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat
Jul 1, 2004·Blood·Guillaume CartronPhilippe Solal-Celigny
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Myron S CzuczmanAntonio J Grillo-López
Jan 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D HainsworthF Anthony Greco
Jan 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas E WitzigDebra A Welker
Feb 4, 2005·The New England Journal of Medicine·Mark S KaminskiRichard L Wahl
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John P LeonardDavid M Goldenberg
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Myron S CzuczmanBryan R Leigh
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jessica L TeelingJan G J van de Winkel
Jul 13, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Lars R PerkGuus A M S van Dongen
Jul 26, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sandra J StraussT Andrew Lister
Aug 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oliver W PressUNKNOWN Southwest Oncology Group
Apr 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael HeroldUNKNOWN East German Study Group Hematology and Oncology Study
May 2, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J P LeonardA Molina
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Elena CitteraJosée Golay
Jun 27, 2007·Seminars in Radiation Oncology·Richard W Tsang, Mary K Gospodarowicz
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amrita KrishnanStephen J Forman
May 6, 2008·Blood·Dimitrios I ZoniosIrini Sereti
May 9, 2008·Blood·Massimo Franchini, Giuseppe Lippi

❮ Previous
Next ❯

Citations

Jul 19, 2013·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Byung Woog KangSang Kyun Sohn
May 31, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Edward B Silberstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.